Free Trial
NYSEARCA:MLPO

Credit Suisse S&P MLP Index ETN (MLPO) Price, Holdings, & News

$14.90 -0.19 (-1.26%)
As of 11/7/2023

About Credit Suisse S&P MLP Index ETN (NYSEARCA:MLPO)

Key Stats

Today's Range
$14.50
$15.70
50-Day Range
$14.90
$14.90
52-Week Range
$9.61
$48.80
Volume
3,400 shs
Average Volume
3,642 shs
Market Capitalization
$33.90 million
Assets Under Management
$30,479.00
Dividend Yield
0.00%
Net Expense Ratio
0.95%
Aggregate Rating
N/A

ETF Overview

Credit Suisse S&P MLP Index ETN Expenses

TypeMLPOEnergy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.00%0.68%0.57%0.52%0.53%
Other Expenses0.00%0.29%0.48%0.56%0.52%
Total Expense0.00%0.77%0.72%0.73%0.71%
Fee Waiver0.00%-0.14%-0.49%-0.65%-0.54%
Net Expense0.95%0.76%0.63%0.58%0.60%
Receive MLPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Credit Suisse S&P MLP Index ETN and its competitors with MarketBeat's FREE daily newsletter.

MLPO ETF News Headlines

Warning: Massive IPO Predicted for May 14?
The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, May 14. And as Fortune has written, this IPO is “larger than any IPO valuation in history”…
Barclays ETN+ Select MLP ETN (ATMP)
Credit Suisse S&P MLP Index ETN (MLPO)
See More Headlines

MLPO ETF - Frequently Asked Questions

Credit Suisse S&P MLP Index ETN's stock was trading at $14.90 on January 1st, 2025. Since then, MLPO stock has increased by 0.0% and is now trading at $14.90.
View the best growth stocks for 2025 here
.

Shares of MLPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Credit Suisse S&P MLP Index ETN investors own include Itron (ITRI), PennantPark Floating Rate Capital (PFLT), Zumiez (ZUMZ), Align Technology (ALGN), Akorn (AKRX), Akebia Therapeutics (AKBA) and Aimmune Therapeutics (AIMT).

Fund Details

Issuer
Credit Suisse
Fund Name
Credit Suisse S&P MLP ETN
Tax Classification
Exchange-Traded Note
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:MLPO
Inception Date
12/2/2014
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P MLP Index
Category
Sector
Focus
Energy
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$30,479.00
Average Daily Volume
$2,817.10
Discount/Premium
-19.47%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
None

Miscellaneous

Beta
N/A
Creation Unit
50,000
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSEARCA:MLPO) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners